Symbol="FNCH"
AssetType="Common Stock"
Name="Finch Therapeutics Group Inc"
Description="Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutic company, is developing a new class of orally administered biologic drugs in the United States. The company is headquartered in Somerville, Massachusetts."
CIK="1733257"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="200 INNER BELT ROAD, SOMERVILLE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="10230300"
EBITDA="-70163000"
PERatio="None"
PEGRatio="None"
BookValue="17.38"
DividendPerShare="0"
DividendYield="0"
EPS="-88.5"
RevenuePerShareTTM="0.158"
ProfitMargin="0"
OperatingMarginTTM="-294.07"
ReturnOnAssetsTTM="-0.315"
ReturnOnEquityTTM="-1.462"
RevenueTTM="253000"
GrossProfitTTM="-57032000"
DilutedEPSTTM="-88.5"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.698"
AnalystTargetPrice="50"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="23.38"
PriceToBookRatio="0.362"
EVToRevenue="6.54"
EVToEBITDA="-0.132"
Beta="0.155"
num_52WeekHigh="86.7"
num_52WeekLow="6.0"
num_50DayMovingAverage="7.99"
num_200DayMovingAverage="13.42"
SharesOutstanding="1604800"
DividendDate="None"
ExDividendDate="None"
symbol="FNCH"
open="6.36"
high="6.54"
low="6.36"
price="6.38"
volume="1907.00"
latest_trading_day="2023-08-25"
previous_close="6.69"
change="-0.31"
change_percent="-4.6401%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="86"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="14"
Volume_recent_avg="179695"
Change_recent_avg="0.02"
Delta_recent_avg="0.37"
Variance_recent_avg="0.19"
Change_ratio_recent_avg="0.54"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="14"
Aroon_momentum_negative="86"
image_negative_thumbnail_id_1="492"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_negative_thumbnail_id_2="1162"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_neutral_thumbnail_id_1="587"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_neutral_thumbnail_id_2="546"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_positive_thumbnail_id_1="994"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
